NASDAQ:CNTX
Context Therapeutics Inc.
- Stock
Last Close
1.68
14/05 20:00
Market Cap
15.49M
Beta: -
Volume Today
99.33K
Avg: 99.97K
PE Ratio
−0.80
PFCF: −0.90
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 2.39M - | 2.27M 5.06% | 1.38M 39.07% | 1.66M 20.15% | ||
average receivables | ||||||
book value per share | -2.35 - | -1.66 29.38% | 17.04 1,127.87% | 2.18 87.22% | 0.74 65.85% | |
capex per share | -0.09 - | -0.03 61.89% | ||||
capex to depreciation | -57.92 - | |||||
capex to operating cash flow | 0.03 - | 0.04 39.46% | ||||
capex to revenue | ||||||
cash per share | 0.02 - | 0.03 50.50% | 17.52 52,339.10% | 2.22 87.31% | 0.91 59.29% | |
days of inventory on hand | ||||||
days payables outstanding | 72.22K - | |||||
days sales outstanding | ||||||
debt to assets | 79.85 - | 12.74 84.05% | 0.00 - | |||
debt to equity | -0.91 - | -0.35 61.41% | 0.00 - | |||
dividend yield | ||||||
earnings yield | -0.14 - | 0.13 188.78% | -0.99 872.82% | -1.37 39.27% | -1.33 3.29% | |
enterprise value | 73.69M - | 57.68M 21.72% | -42.10M 172.98% | -25.04M 40.53% | 3.59M 114.35% | |
enterprise value over ebitda | -13.70 - | -22.43 63.65% | 5.76 125.67% | 1.74 69.73% | -0.14 108.23% | |
ev to operating cash flow | -25.98 - | -55.75 114.58% | 4.78 108.58% | 1.85 61.37% | -0.17 109.24% | |
ev to sales | ||||||
free cash flow per share | -0.28 - | -0.10 63.52% | -3.19 3,051.45% | -0.88 72.37% | -1.32 49.42% | |
free cash flow yield | -0.05 - | -0.02 63.52% | -1.20 5,942.25% | -1.35 12.76% | -1.17 13.82% | |
graham net net | -2.35 - | -1.67 28.99% | 16.45 1,084.94% | 2.02 87.70% | 0.64 68.23% | |
graham number | 6.22 - | 4.93 20.82% | 31.71 543.67% | 6.62 79.12% | 5.01 24.32% | |
income quality | 0.44 - | -0.16 135.05% | 0.84 640.42% | 0.91 8.53% | 0.88 3.83% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -4.89 - | -3.89 20.39% | -163.85 4,112.11% | -28.11 82.85% | ||
interest debt per share | 2.25 - | 0.65 71.17% | 0.02 96.50% | 0.04 66.42% | ||
inventory turnover | ||||||
invested capital | -0.91 - | -0.35 61.41% | 0.00 - | |||
market cap | 52.07M - | 52.07M 0% | 7.54M 85.52% | 10.41M 38.04% | 18.04M 73.39% | |
net current asset value | -23.99M - | -17.04M 28.99% | 48.22M 383.01% | 34.65M 28.15% | 11.86M 65.78% | |
net debt to ebitda | -4.02 - | -2.18 45.72% | 6.79 411.02% | 2.47 63.66% | 0.58 76.62% | |
net income per share | -0.73 - | 0.65 188.78% | -2.62 503.08% | -0.90 65.88% | -1.50 67.69% | |
operating cash flow per share | -0.28 - | -0.10 63.52% | -3.11 2,964.39% | -0.85 72.67% | -1.32 55.34% | |
payables turnover | 0.01 - | |||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -27.36 - | 14.22 151.96% | -0.14 101.02% | -0.38 159.80% | -1.49 296.36% | |
revenue per share | ||||||
roe | 0.31 - | -0.39 225.71% | -0.15 60.79% | -0.41 167.00% | -2.02 391.00% | |
roic | 2.98 - | 0.21 92.91% | -0.16 173.40% | -0.42 174.13% | -2.11 397.07% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -2.35 - | -1.66 29.38% | 17.04 1,127.87% | 2.18 87.22% | 0.74 65.85% | |
stock based compensation to revenue | ||||||
tangible asset value | -23.96M - | -16.92M 29.38% | 48.27M 385.28% | 34.76M 28.00% | 11.87M 65.85% | |
tangible book value per share | -2.35 - | -1.66 29.38% | 17.04 1,127.87% | 2.18 87.22% | 0.74 65.85% | |
working capital | -23.87M - | -9.20M 61.46% | 48.22M 624.24% | 34.65M 28.15% | 11.86M 65.78% |
All numbers in USD (except ratios and percentages)